by EmpathiCSubstanceS | Nov 6, 2020 | Psychedelic Medicine
A sixth religious group in Canada has been granted an exemption to use the hallucinogenic tea, known for causing visions and vomiting, as part of its ceremonies A church in Winnipeg, Manitoba just became the latest to get a government exemption to legally import and...
by EmpathiCSubstanceS | Nov 6, 2020 | Psychedelic Medicine
Phase 1 Trial to experiment with dosing methods to better understand how humans react to DMT, setting stage for future potential Phase 2a proof of concept trials BASEL, Switzerland, June 18, 2020 /PRNewswire/ — MindMed will now pursue N,N-Dimethyltryptamine...
by EmpathiCSubstanceS | Nov 6, 2020 | Psychedelic Medicine
By Jasmine Virdi As the use of ayahuasca becomes increasingly widespread, the Amazonian vine has extended its roots beyond the traditional indigenous and religious contexts of South America, lending itself to a newly evolving field of practice. However, the economic...
by EmpathiCSubstanceS | Nov 6, 2020 | Pain
The compound, called 2 C-H, reduces inflammation without mind-altering effects People have long believed that using psychedelic drugs such as LSD, DMT, and psilocybin (from ″magic mushrooms”) can help the body fight inflammation. Scientific support for this idea...
by EmpathiCSubstanceS | Nov 6, 2020 | Neuropathy
In a May 2020 paper published in the journal Regional Anesthesia and Pain Medicine, researchers from the University of California San Diego reviewed the psychedelic literature and proposed a mechanism by which psychedelics may relieve chronic pain.1 The literature...
